|
|
|
|
|
|
The Drug Studies Unit, Analytical Division, specializes in the
development of methods needed to detect and quantify drug substances in
biological fluids. Our methodologies are applied to the testing of drug
treatments and therapies of major importance in human health and
well-being. We strive to secure and succeed in a variety of educational,
pharmaceutical industry and governmental projects, for it is these projects
that offer our staff and academic personnel the opportunity to develop
their abilities and apply their expertise to advance our understanding of
problems in drug research. To meet our fullest potential as individuals and
as an organization, the DSU must recognize and nurture an environment of
togetherness and harmony, cherishing the contributions of each member and
celebrating diversity.
|
|
|
|
The Analytical Division of the Drug Studies Unit (DSU)
applies Good Laboratory Practice (GLP) standards to meet the drug assay
development requirements necessary in submissions to the Food and Drug
Administration. The DSU was established in 1977 by the late Dr. Sid
Riegelman, Dr. Leslie Benet (former Chairman of the Department of
Biopharmaceutical Sciences, now the Department of Bioengineering and Therapeutic Sciences) and Dr. Roger Williams (USP). With over 25
years experience in drug and metabolite analysis of biological fluids,
method development and validation, the Drug Studies Unit serves as an
educational, scientific and financial resource of the Department of Bioengineering and Therapeutic Sciences
in the School of Pharmacy at the
University of California, San Francisco.[More about
us]
|
|
|
|
The DSU is equipped with state of the art analytical
equipment (including mass spectrometers) which performs automated sampling,
computerized data acquisitions and report preparation. Automated equipment
and computerized data acquisitions systems allow expeditious study
execution. [More about our facilities]
|
|
